This is the final report for the INNOVA-P2 project which addressed the problem that is evident in the current international intellectual property regime with regard to the pharmaceutical sector: developing new drugs requires monopoly protection to help inventors recuperate their investments, but the same protection system is becoming a major obstacle preventing less well-off (i.e. the global majority) patients from accessing new medicines. The report covers the project from start to finish and highlights the actions undertaken and final results.
Download application/zip (2862259)
Record Number: 14105 / Last updated on: 2013-01-08